Value-Based Dermatology with Independent Health

‍‍For many health plans, dermatology has become a top-three driver of pharmacy spend, often trapped in a cycle of “forever medications” and rising costs. Our latest case study features Independent Health, a regional not-for-profit plan that faced over $100 million in annual dermatology drug spend.

By moving beyond traditional utilization management and implementing Zest’s value-based clinical model, Independent Health achieved a 3.3:1 ROI while improving member outcomes.

Key Highlights:

• ‍Proven Savings: Achieved >$17,000 Per Enrollee Per Year in net savings.
• Clinical Excellence: 94% of members achieved improved or stable disease states.
• ‍Right-Sized Care: Transitioned 53% of enrollees from high-cost systemics to clinically appropriate maintenance care.

As Kelly Verrall, VP of Pharmacy at Independent Health, notes, this partnership delivered results that “would not have been achievable through traditional utilization management alone.”

Read the case study below to see the data-driven framework Zest uses to stabilize specialty spend and deliver remission-centered care.